SANA Capsules
- Batch
- Eppixlabs.com
- Tested by
- Janoshik
- Tested on
- 2026-09-24
- Added
- 2026-10-03
SANA Capsules
SANA Capsules USA — Capsules
Research Capsule Compound
SANA Capsules are supplied as a capsule-format research material. The molecular profile provided corresponds to a formula of C19H25N5O8 with a molecular weight of approximately 451.4. The product is intended strictly for laboratory research use.
This product is intended strictly for laboratory research use within the United States. It is not approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable U.S. federal, state, and local regulations.
SANA Capsules are supplied as a capsule-format research material. The molecular profile provided corresponds to a formula of C19H25N5O8 with a molecular weight of approximately 451.4. The product is intended strictly for laboratory research use.
The published literature indexed under the designation "SANA" does not describe this molecular entity. The available records use the same letters for unrelated subjects, including a bacterial inner membrane protein, a gold nano-aggregate antimicrobial construct, a computational network alignment method, and a wound dressing trade name. No published characterisation of the compound represented by this molecular profile could be established from the candidate literature.
Third-party tested for purity, ID, quantity.
Coming Soon
The certificate of analysis for this lot is being finalised and will be published here as soon as the lab returns it.
No mechanism of action can be attributed to this compound on the basis of the available references. The designation "SANA" appears in the literature as an acronym and as a surname across unrelated fields, and none of those records examine a small molecule matching the supplied formula and molecular weight. Any mechanistic description would therefore be unsupported.
For context on how the abbreviation is used elsewhere: it has been applied to sceptrin-gold nano-aggregates investigated against drug-resistant Gram-negative bacteria, to SanA, an inner membrane protein studied in Salmonella Typhimurium in relation to membrane properties and xenobiotic resistance, and to a topological network alignment algorithm used for cross-species prediction of Gene Ontology annotations. These are distinct subjects and should not be read as describing the product on this page. Research endpoints for the compound itself are not documented in the sources available.
The origin of this compound under the SANA designation is not well documented. The candidate literature contains no synthesis report, no discovery account, and no development history corresponding to the supplied molecular profile.
Where the published record uses the term, it does so for separate subjects that developed independently of one another: microbiological work on the Salmonella SanA protein, nanomaterial chemistry work on sceptrin-gold aggregates, and bioinformatics work on network alignment software. Readers should treat the name as ambiguous in the literature rather than as a pointer to an established research compound.
The published record available for this designation is limited and does not address the compound supplied here. Indexed work using the SANA name covers unrelated areas: antimicrobial nanomaterial constructs evaluated against drug-resistant Gram-negative organisms, bacterial membrane protein function in Salmonella Typhimurium infection and xenobiotic resistance, and computational methods for cross-species annotation transfer. No research framework specific to the molecular entity described by the supplied profile could be identified.
3 of the 4 areas below are addressed directly by a paper cited on this page.
Literature with ambiguous SANA nomenclature
Addressed on this page by An 2022, Stypułkowska 2025, Aleksandrowicz 2023. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- An, JM. et al. (2022) — Sceptrin-Au nano-aggregates (SANA) for overcoming drug-resistant Gram-negative bacteria
- Stypułkowska, A. et al. (2025) — SanA is an inner membrane protein mediating Salmonella Typhimurium infection
- Aleksandrowicz, A. et al. (2023) — Membrane properties modulation by SanA: implications for xenobiotic resistance in Salmonella Typhimurium
Bacterial membrane protein studies (SanA, Salmonella)
Addressed on this page by Stypułkowska 2025, Aleksandrowicz 2023, An 2022. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Stypułkowska, A. et al. (2025) — SanA is an inner membrane protein mediating Salmonella Typhimurium infection
- Aleksandrowicz, A. et al. (2023) — Membrane properties modulation by SanA: implications for xenobiotic resistance in Salmonella Typhimurium
- An, JM. et al. (2022) — Sceptrin-Au nano-aggregates (SANA) for overcoming drug-resistant Gram-negative bacteria
Antimicrobial nanomaterial constructs
No paper cited on this page reports on antimicrobial, nanomaterial or constructs. This heading marks where SANA Capsules is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
Computational network alignment methods
Addressed on this page by Wang 2022. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Wang, S. et al. (2022) — SANA: cross-species prediction of Gene Ontology GO annotations via topological network alignment
The references section of this page cites 4 primary papers published between 2022 and 2025 — a limited but non-trivial record. Every citation is linked to its PubMed or DOI record so it can be read rather than taken on trust, and the summaries above describe what those papers report rather than what the compound is claimed to do.
SANA Capsules is frequently listed as a peptide by suppliers in this market. It is not one. The structure published on this page is the compound's actual chemistry, and research on it should be read against its own class rather than against peptide literature.
Research compounds attract claims that outrun their evidence. Below are the ones most often encountered for SANA Capsules, set against what the papers cited on this page actually report. Where the record is thin or contested, that is stated rather than smoothed over.
SANA Capsules is commonly described online in connection with stronger immune function and resistance to infection. In the research literature the same compound is filed under literature with ambiguous SANA nomenclature, bacterial membrane protein studies (SanA, Salmonella) and antimicrobial nanomaterial constructs.
The 4 papers cited on this page, published between 2022 and 2025 describe laboratory and animal work. None reports a controlled trial in humans. Findings in cell culture or in a rodent model describe what happened in that system; they do not establish that the same occurs in humans, and this compound is not approved for human use.
Nothing above is a statement of what this material does. It is a summary of what has been published and what has not. Eppix Labs supplies research materials only and provides no dosing, administration or protocol guidance.
Verification for SANA Capsules is per lot, not per product. The current lot Eppixlabs.com returned 106.61 mg measured, assayed by Janoshik. Those figures are the laboratory's, published in full rather than reduced to a badge.
The lot code printed on the bottle matches the code on the certificate for SANA Capsules. Matching the two is what confirms the unit in hand came from the batch that was tested — a certificate not tied to a lot code proves nothing about any particular unit.
Researchers who buy SANA Capsules in the United States through Eppix Labs receive the lot described by the certificate above: the code printed on the vial label is the code on the certificate, and both are searchable on the batch verification page.
- Storage
- Cool, dry, away from direct light
- Humidity
- Keep sealed; capsule shells are hygroscopic
- Reconstitution
- Not applicable — supplied pre-measured
- Format
- Oral capsule
SANA Capsules is supplied in capsule form, which removes the reconstitution step entirely: there is no vehicle to add, no reconstitution volume to record and no post-reconstitution stability window to track. What that leaves a laboratory to control is storage — capsule shells draw moisture from the air, so the container should be kept sealed and dry rather than decanted into an open vessel.
Because the material is already at its labelled quantity per capsule, batch verification carries more weight in this format than it does for powder: there is no point at which the researcher independently confirms mass by weighing. The measured content published for each lot is the figure that answers that question.
- 1 × sealed capsule bottle (100mg per capsule / Single Bottle - Pack of 60), batch-labelled
- Batch documentation for the lot shipped, once its certificate is published
- Discreet outer packaging with no product names on the exterior
- FedEx, tracked, typically 1–3 business days domestically
- Laboratory consumables of any kind
- Dosing, administration or protocol guidance of any kind
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each capsule contains the labeled quantity of the compound. Independent third-party analysis verifies purity, identity, and net content per batch.
The product is supplied in capsule form only. Any laboratory materials required for extraction, preparation, or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
Sceptrin-Au nano-aggregates (SANA) for overcoming drug-resistant Gram-negative bacteria
PubMedSanA is an inner membrane protein mediating Salmonella Typhimurium infection
PubMedMembrane properties modulation by SanA: implications for xenobiotic resistance in Salmonella Typhimurium
PubMedSANA: cross-species prediction of Gene Ontology GO annotations via topological network alignment
PubMedRelated
You May Also Like
Fisetin-Derived Research Compound CMS-121 is a synthetic small molecule derived from the plant flavonoid fisetin, produced for laboratory research use only. It is supplied in capsule form for controlled experimental work and is not intended for any other application.
$29.99
Methylated Beta-Carboline Alkaloid 9-Me-BC (9-methyl-beta-carboline) is a small methylated beta-carboline alkaloid studied in neurochemical research models. It is supplied in capsule form strictly for laboratory research use.
$64.99
Uncharacterised Research Compound Compound-7P is supplied as capsules for laboratory research use. The designation "Compound-7P" is a non-systematic label and does not correspond to a single identified chemical entity in the published chemical or pharmacological literature. No PubChem record matches the name, and no molecular formula, sequence or structural profile was supplied with it.
$49.99
Redox-Active Flavin Analogue 5-Deazaflavin is a synthetic analogue of the flavin ring system in which the nitrogen at position 5 of the isoalloxazine core is replaced by carbon. The parent heterocycle (C11H7N3O2, MW 213.19) and its substituted derivatives are produced for laboratory research and are handled within controlled experimental environments.
$59.99